 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Soneryl |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | Liver |
| Excretion | Kidney |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.928 |
| Chemical and physical data | |
| Formula | C10H16N2O3 |
| Molar mass | 212.249 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Butobarbital, also calledbutobarbitone orbutethal,Soneryl, andNeonal,[1] is a hypnotic drug which is abarbiturate derivative.[2] It was developed by Poulenc Brothers (now part of Sanofi) in 1921.[3]
